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Management of 
soil-transmitted 
helminthiasis in surgical 
candidates for obstetric 
ﬁ stula repair
Subspecialty surgical care delivered 
through short-term medical missions 
is essential to reduce unmet need 
for surgical services in low-income 
countries, but to deliver value for 
patients, such projects must be 
integrated into the existing health-
system infrastructure.1,2 According 
to the care delivery value chain 
framework proposed by Kim and 
colleagues,2 patients derive added 
value—or health—when providers 
depart from a single intervention 
mindset and take into consideration 
the full spectrum of patients’ 
circumstances. Farmer and colleagues1 
put forward a vision for global surgery 
in which diverse experts join together 
to develop and implement sustainable 
solutions to complex surgical problems 
that maximise value for patients who 
have to overcome signiﬁ cant barriers, 
such as distance and cost, to seek 
treatment. We worked with visiting 
and host providers at Kibagabaga 
District Hospital in Kigali, Rwanda, 
the site dedicated to treatment and 
management of maternal birth-rela ted 
trauma, to form an international and 
interdisciplinary working group to 
develop a standardised protocol to 
guide the management of patients 
diagnosed with both obstetric ﬁ stula 
and soil-transmitted helminthiasis. 
The protocol was aimed at lessening 
the likelihood that value created by the 
treated illness would be negated by the 
untreated one.
Obstetric fistula is a birth-related 
pelvic injury resulting from prolonged 
and obstructed labour and is 
characterised by involuntary loss of 
urine, faecal matter, or both.3 Obstetric 
fistula affects more than 2 million 
women residing mainly in low-income 
countries located in sub-Saharan 
Africa and Asia who do not have 
access to proper care during pregnancy 
and childbirth.4 Between 50 000 and 
100 000 new cases occur each year.4 
In Rwanda, a central and east African 
nation of 11 million people, soil-
transmitted helminthiasis is endemic, 
with prevalence reported to be more 
than 50% of the population.5 As a 
result, soil-transmitted helminthiasis 
is a frequent comorbidity in patients 
with obstetric fistula admitted to 
Kibagabaga District Hospital for 
surgical intervention. Despite a risk 
profile unique to patients infected 
with soil-transmitted helminths 
in perioperative settings that 
suggests the potential for serious 
complications, there is no consensus 
among practitioners who specialise 
in management of patients with 
pelvic floor disorders on the best 
way to handle patients with both 
obstetric ﬁ stula and soil-transmitted 
helminthiasis.
In a randomised controlled trial Koul 
and colleagues6 found that patients 
diagnosed with pulmonary hydatid 
disease treated with combined 
albendazole and praziquantel for 
4 weeks before surgery showed the 
greatest decrease in scolice viability 
compared with untreated patients 
and those treated for 2 weeks. Our 
working group extrapolated from this 
finding that, in surgical candidates 
with soil-transmitted helminthiasis, 
treatment of infection should take 
place before elective, non-emergency 
surgery. We identified additional 
compelling evidence to support the 
decision to delay surgery even when 
anthelmintic chemotherapy has been 
initiated, in the observed physiological 
response to anthelmintic agents.7 First, 
anthelmintic chemotherapy induces 
hyperactivity in parasites as they seek 
other sites to invade in a bid to escape 
death. In the perioperative context, 
parasite hyperactivity poses a threat 
to the integrity of the airway. When 
parasites migrate up the oesophagus, 
pulmonary aspiration of scolices can 
occur. Second, persistent emesis in 
the perioperative period can result 
in underdosing, thus reducing the 
efficacy of anthelmintic agents. 
Third, some antibiotics and anti-
inflammatory drugs administered 
during the perioperative period can 
interfere with the bioavailability of 
anthelmintic drugs.7
Creation of synergy between the 
host and visiting providers through 
respectful interdisciplinary partnerships 
facilitated shared resources to develop 
and implement a sustainable solution 
to a complex surgical problem. Most 
importantly, strong relationships that 
continue to bridge the divides between 
high-income and low-income countries 
and between non-governmental 
organisations and governments form 
the building blocks for an integrated, 
high-value global health delivery 
system.2,8
We declare no competing interests.
Copyright © Ng’ang’a et al. Open Access article 
distributed under the terms of CC-BY-NC-ND.
*Njoki Ng’ang’a, Karolynn Echols, 
Fatai Ilupeju, Ramses Kalumbi
nnganga@hackensackumc.org
International Organization for Women & 
Development, Rockville Centre, New York, USA (NN, 
KE, FI); Department of Obstetrics and Gynecology, 
Hackensack University Medical Center, Hackensack, 
New Jersey, USA (NN); Department of Obstetrics and 
Gynecology, Cooper University Hospital, Voorhees, 
New Jersey, USA (KE); Anesthesia Associates of 
Massachusetts, Westwood, Massachusetts, USA (FI); 
Department of Obstetrics & Gynecology, Muhima 
Hospital, Kigali, Rwanda (RK)
1  Farmer PE, Kim JY. Surgery and global health: 
a view from beyond the OR. World J Surg 2008; 
32: 533–36.
2 Kim JY, Farmer P, Porter ME. Redeﬁ ning global 
health-care delivery. Lancet 2013; 382: 1060–69.
3 Meeks, GR, Roth, TM. Vesicovaginal and 
urethrovaginal ﬁ stulas. In: Rock JA, 
Jones HW III, eds. Te Linde’s operative 
gynecology. Philadelphia: Lippincott, Williams 
& Wilkins, 2011: 1099–120.
4 WHO. 10 facts on obstetric ﬁ stula. 2010. 
http://www.who.int/features/factﬁ les/
obstetric_ﬁ stula/en/  (accessed Jan 26, 2014).
5 WHO. Country proﬁ le: Rwanda (neglected 
tropical diseases: preventive chemotherapy & 
transmission control. 2010. http://www.who.
int/neglected_diseases/preventive_
chemotherapy/databank/CP_Rwanda.pdf 
(accessed Jan 26, 2014). 
6 Koul PA, Singh AA, Ahanger AG, Wahid A, 
Soﬁ  BA. Optimal duration of preoperative 
anti-helminthic therapy for pulmonary 
hydatid surgery.  ANZ J Surg 2008; 80: 354–57.
Published Online
May 23, 2014
http://dx.doi.org/10.1016/
S2214-109X(14)70244-X
Correspondence
e394 www.thelancet.com/lancetgh   Vol 2   July 2014
7 Working group on soil transmitted 
helminthiasis. Monitoring anthelminthic 
eﬃ  cacy for soil transmitted helminths. 2008. 
http://www.who.int/neglected_diseases/
preventive_chemotherapy/Chemotherapy_
anthelminthic_drug_WHO_WB_ﬁ nal.pdf 
(accessed Jan 30, 2014).
8 Meara JG, Hagander L, Leather AJM. Surgery 
and global health: a Lancet commission. Lancet 
2014; 383: 12–13.
